| 1997 |
NDUFS8 (TYKY subunit) contains two clusters of four conserved cysteine residues and encodes a 210-amino-acid precursor with a 34-amino-acid N-terminal mitochondrial targeting presequence; the mature protein is 92% identical to the bovine subunit and 72% to the Rhodobacter capsulatus NuoI counterpart, establishing it as an iron-sulfur subunit of Complex I. |
cDNA sequencing, deduced protein analysis, chromosomal mapping |
Biochimica et biophysica acta |
Medium |
9116042
|
| 1997 |
Deletion of the NuoI (TYKY ortholog) gene or mutation of a conserved cysteine (C74S) in Rhodobacter capsulatus abolishes Complex I activity, eliminates EPR signals for FeS clusters N1 and N2, and prevents assembly of peripheral subunits, demonstrating that NuoI is required for connecting the peripheral and membraneous domains of Complex I. |
Homologous recombination deletion, site-directed mutagenesis (C74S), EPR spectroscopy, immunochemical analysis, trans-complementation |
European journal of biochemistry |
High |
9428698
|
| 1997 |
The TYKY/NDUFS8 homolog in Neurospora crassa is closely associated with the peripheral arm of Complex I, as shown by co-purification and antiserum-based localization. |
Heterologous expression in E. coli, purification, antibody production, biochemical fractionation |
Biochimica et biophysica acta |
Medium |
9452770
|
| 1998 |
The mature NDUFS8/TYKY protein has a molecular mass of ~22 kDa and a pI of 4.9–5.0, as determined by 2D gel electrophoresis and immunodetection; the gene spans ~6 kb with seven exons, and its promoter contains Sp1 and NRF1 binding site motifs in the first intron, with ubiquitous expression predominant in heart and skeletal muscle. |
Genomic sequencing, 2D gel electrophoresis, immunodetection |
Gene |
Medium |
9666055
|
| 2002 |
Transcription of NDUFS8 is driven by a minimal 247-bp basal promoter containing three Sp1 sites and one YY1 site; gel-shift analysis and site-directed mutagenesis showed that the YY1 site and two adjacent Sp1 sites are the primary drivers of promoter activity. |
Primer extension, reporter gene assay (HeLa and C2C12 cells), gel-shift (EMSA), site-directed mutagenesis |
Biochimica et biophysica acta |
High |
11955626
|
| 2003 |
The NuoI (TYKY) subunit of Complex I binds two distinct [4Fe-4S] clusters, named N2a and N2b, each coordinated by a separate set of conserved cysteine residues; cysteine mutants C67S and C106S each caused a 50% decrease in the EPR N2 signal, demonstrating that both N2 clusters reside on this subunit. |
Site-directed mutagenesis of five cysteine residues, EPR spectroscopy of membrane fractions, NADH:ubiquinone oxidoreductase activity assays |
Biochimica et biophysica acta |
High |
12615348
|
| 2004 |
Compound heterozygous mutations in NDUFS8 in a Leigh syndrome patient cause reduced levels of the NDUFS8 polypeptide and secondary reductions in other nuclear-encoded Complex I subunits, indicating NDUFS8 is essential for the assembly or stability of the Complex I holoenzyme. |
Mutation analysis, Western blot of patient-derived tissue |
Neurology |
Medium |
15159508
|
| 2021 |
TAT-fused NDUFS8 fusion proteins are transduced into mitochondria in a membrane-potential-independent manner, are correctly processed, rescue Complex I assembly, and partially restore Complex I activity in NDUFS8-deficient cells. |
Recombinant TAT-fusion protein production, cell transduction, mitochondrial fractionation, in-gel activity assay, oxygen consumption assay |
International journal of molecular sciences |
Medium |
34204592
|
| 2022 |
Disease-associated mutations in NDUFS8 (mapped to the nuoI locus in E. coli Complex I) disrupt Complex I assembly; co-immunoprecipitation and time-delayed expression assays confirmed that certain mutations act at subunit interfaces, and compound heterozygote modeling identified the more deleterious mutation in each pair. |
Site-directed mutagenesis in E. coli homolog (nuoI), deamino-NADH oxidase activity, co-immunoprecipitation, assembly assay |
Mitochondrion |
Medium |
36462614
|
| 2024 |
NDUFS8 knockdown or knockout in endothelial cells reduces Complex I activity, decreases ATP production, depolarizes mitochondria, and increases ROS; these effects impair the Akt-mTOR signaling cascade, which is rescuable by exogenous ATP. Conversely, NDUFS8 overexpression promotes Akt-mTOR activation, cell proliferation, migration, and tube formation. Endothelial-specific NDUFS8 knockdown in vivo inhibits retinal angiogenesis. |
shRNA/CRISPR-Cas9 KO, oxygen consumption assay, ATP assay, ROS measurement, mitochondrial membrane potential assay, Akt-mTOR pathway analysis, constitutively-active Akt1 rescue, AAV-mediated in vivo knockdown, retinal angiogenesis assay |
Cell death & disease |
High |
38594244
|
| 2025 |
HUWE1 is an E3 ubiquitin ligase that ubiquitinates NDUFS8 at lysine 88, regulating its protein stability; NDUFS8 localizes to mitochondria, promotes Complex I activity and ATP production in hepatocellular carcinoma cells, and its loss increases ROS, disrupts redox homeostasis, and induces apoptosis. |
Mass spectrometry, co-immunoprecipitation, ubiquitination assay, mitochondrial fractionation, shRNA/KO/OE functional assays, xenograft mouse model |
Translational oncology |
Medium |
40914145
|
| 2026 |
NRF2 regulates NDUFS8 transcription by binding both ARE and non-ARE motifs in the NDUFS8 promoter; cytoplasmic NRF2 also stabilizes NDUFS8 protein post-translationally. AAV-mediated NDUFS8 restoration in basal forebrain rescues spatial memory deficits in chronic cerebral hypoperfusion rats by enhancing mitochondrial oxidative phosphorylation. |
Dual-luciferase reporter assay, chromatin immunoprecipitation (ChIP), computational simulation, stereotaxic AAV injection with gain/loss-of-function, behavioral memory assay, mitochondrial OXPHOS measurement |
Theranostics |
Medium |
41355955
|